Therapeutic and Site Capabilities
Eximia Research supports Phase I–IV clinical trials across a broad range of therapeutic areas, including:
- Cardiology and vascular disease
- Endocrinology, diabetes, obesity, and other metabolic conditions
- Gastroenterology and hepatology
- Family and internal medicine
- Nephrology
- Pulmonology and respiratory disease
- Infectious disease and vaccines
- Neurology and pain management
- Women’s health
- Psychiatry, behavioral health, and psychedelic research
- Dermatology
- Rheumatology
- Healthy volunteer studies
- Pediatrics
Across the network, Eximia Research sites offer experienced investigators and full-time research staff supported by centralized regulatory, quality, operational, data, technology, and patient-engagement teams. Site-level capabilities vary by location and may include dedicated exam and infusion space, on-site laboratory processing, temperature-controlled investigational product storage, ECGs, spirometry, phlebotomy, specimen processing and shipping, refrigerated and frozen storage, FibroScan, ultrasound, and other radiological testing. Eximia evaluates each opportunity against the investigator experience, patient population, staffing, equipment, and procedural capabilities of the most appropriate sites.
"*" indicates required fields